-transparent.png){kind=logo}
Vascular endothelial cell adhesion molecule 1 (VCAM-1) is an adherence molecule that is induced on endothelial cells by cytokine stimulation and can mediate binding of lymphocytes or tumor cells to endothelium. Because these interactions often occur at the level of the microvasculature, we have examined the regulation of expression of VCAM-1 in human dermal microvascular endothelial cells (HDMEC) and compared it to the regulation of VCAM-1 in large vessel human umbilical vein endothelial cells (HUVEC). Both cell populations were judged pure as assessed by expression of von Willebrand factor and uptake of acetylated low density lipoprotein. Expression of VCAM-1 was not detectable on either unstimulated HDMEC or HUVEC when assessed by ELISA or flow cytometry. Stimulation of either HDMEC or HUVEC with TNF-alpha resulted in a time- and dose-dependent induction of VCAM-1. However, although TNF-alpha-induced cell surface and mRNA expression of VCAM-1 in HDMEC was transient, peaking after 16 h of stimulation, TNF stimulation led to persistently elevated cell surface expression of VCAM-1 on HUVEC. IL-1 alpha also induced cell surface expression of VCAM-1 on HUVEC in a time- and dose-dependent manner, but stimulation of HDMEC with IL-1 alpha at doses up to 1000 U/ml failed to induce significant cell surface expression. However, IL-1 alpha induced time- and dose-dependent increases in ICAM-1 on HDMEC. Similarly, IL-4 induced VCAM-1 expression and augmented TNF-alpha-induced expression on HUVEC but did not affect VCAM-1 expression on HDMEC. Binding of Ramos cells to cytokine-stimulated endothelial cell monolayers correlated with VCAM-1 induction. Increased binding was seen after stimulation of HDMEC with TNF-alpha, which was blocked by anti-VCAM-1 mAb, but no increases in binding were noted after stimulation of HDMEC monolayers with IL-1 alpha. These data provide additional evidence for the existence of endothelial cell heterogeneity and differences in cell adhesion molecule regulation on endothelial cells derived from different vascular beds.
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
November 2003,
The Journal of investigative dermatology,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
August 1996,
The Kobe journal of medical sciences,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
February 1997,
The Journal of clinical investigation,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
September 1994,
The British journal of dermatology,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
January 1996,
Blood,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
August 1994,
Biochemical and biophysical research communications,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
February 1994,
Circulation research,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
April 1996,
Journal of immunology (Baltimore, Md. : 1950),
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
May 2001,
Veterinary immunology and immunopathology,
R A Swerlick, and
K H Lee, and
L J Li, and
N T Sepp, and
S W Caughman, and
T J Lawley
August 1991,
The Journal of investigative dermatology,
